Join the Cough group to help and get support from people like you.
Cough News (Page 2)
Related terms: Chronic Cough, Cough, chronic, Tussis, Acute cough, Persistent cough, Chesty cough, Dry Cough
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
FDA Medwatch Alert: Licorice Coughing Liquid OTC Cough Syrup by Ma Ying Long Pharmaceutical Group: CDER Alert - Contains Unidentified Morphine
[Posted 01/16/2016] ISSUE: The FDA is warning consumers not to use Licorice Coughing Liquid, a cough syrup product sold over-the-counter, because it contains unidentified morphine. The cough syrup’s ...
FDA Medwatch Alert: Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid by Perrigo Company: Recall - Potential Defect with Dosage Cup
Including store brands: Sunmark Rite-Aid Topcare Kroger GoodSense Dollar General Care One CVS ISSUE: Perrigo Company announced that, following the recent recall of certain dosing cups b...
FDA Medwatch Alert: Codeine Cough-and-Cold Medicines in Children: Drug Safety Communication - FDA Evaluating Potential Risk of Serious Side Effects
ISSUE: FDA is investigating the safety of using codeine-containing medicines to treat coughs and colds in children under 18 years because of the potential for serious side effects, including slowed...
Vernalis and Tris Pharma Receive FDA Approval for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex)
May 1, 2015 – Vernalis plc and Tris Pharma Inc. today announce that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and...
Pernix Therapeutics Receives FDA Approval for Vituz
THE WOODLANDS, Texas--(BUSINESS WIRE)--Feb 28, 2013 - Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced that its subsidiary, Hawthorn Pharmaceuticals, Inc., has...
FDA Medwatch Alert: Influend Cough and Cold Products
[Posted 04/16/2009] ION Labs and FDA notified consumers and healthcare professionals of the recall of all Influend Cough and Cold products sold on or after May 30, 2008 due to the possibility that...
FDA Medwatch Alert: Cough and Cold Medications in Children Less Than Two Years of Age - Jan 17, 2008
[Posted 01/17/2008] FDA informed consumers and healthcare professionals that the Agency has completed its review of information regarding the safety of over-the-counter (OTC) cough and cold medicines...
FDA Medwatch Alert: Nonprescription Cough and Cold Medicine Use in Children
[Posted August 15, 2007] FDA announced that on October 18 - 19, 2007, the Nonprescription Drugs Advisory Committee will discuss the safety and effectiveness of cough and cold drug product use in...
FDA Medwatch Alert: Cough and Cold Medications in Children Less Than Two Years of Age - Jan 12, 2007
[Posted 01/12/2007] The Centers for Disease Control and Prevention (CDC) issued a Morbidity and Mortality Weekly Report (MMWR) article describing three deaths in U.S. infants aged less than 12 months...
FDA Medwatch Alert: Long-Acting Hydrocodone-Containing Cough Product (marketed as Tussionex Pennkinetic Extended-Release Suspension)
[Posted 03/11/2008] FDA informed healthcare professionals of life-threatening adverse events and death in patients, including children, who have received Tussionex Pennkinetic Extended-Release...
Further information
Related drug support groups
gabapentin, amitriptyline, Benadryl, Mucinex, codeine, diphenhydramine, benzonatate, Dilaudid, Mucinex DM, view more... Lortab, guaifenesin, acetaminophen / hydrocodone, Daytime, dextromethorphan, hydromorphone, Alka-Seltzer